Clinical Trials
5
Active:0
Completed:5
Trial Phases
1 Phases
Phase 3:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 3
5 (100.0%)Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012)
Phase 3
Completed
- Conditions
- Hepatitis BPertussis
- First Posted Date
- 2016-05-03
- Last Posted Date
- 2020-06-09
- Lead Sponsor
- MCM Vaccines B.V.
- Target Recruit Count
- 754
- Registration Number
- NCT02759354
Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)
Phase 3
Completed
- Conditions
- Bacterial InfectionsVirus DiseasesNeisseria Meningitidis
- First Posted Date
- 2013-04-24
- Last Posted Date
- 2019-02-25
- Lead Sponsor
- MCM Vaccines B.V.
- Target Recruit Count
- 385
- Registration Number
- NCT01839188
Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)
Phase 3
Completed
- Conditions
- Neisseria MeningitidisBacterial InfectionsVirus Diseases
- First Posted Date
- 2012-03-14
- Last Posted Date
- 2019-03-28
- Lead Sponsor
- MCM Vaccines B.V.
- Target Recruit Count
- 284
- Registration Number
- NCT01553279
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)
Phase 3
Completed
- Conditions
- Bacterial InfectionsVirus Diseases
- First Posted Date
- 2011-11-28
- Last Posted Date
- 2019-04-02
- Lead Sponsor
- MCM Vaccines B.V.
- Target Recruit Count
- 1315
- Registration Number
- NCT01480258
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)
Phase 3
Completed
- Conditions
- Virus DiseasesBacterial Infections
- First Posted Date
- 2011-04-26
- Last Posted Date
- 2019-04-30
- Lead Sponsor
- MCM Vaccines B.V.
- Target Recruit Count
- 1250
- Registration Number
- NCT01341639
News
No news found